AstraZeneca resumes UK trials of COVID-19 vaccine halted by patient illness
AstraZeneca has resumed British clinical trials of its COVID-19 vaccine, one of the most advanced in development, after getting the green light from safety watchdogs, the company said on Saturday.
View the full story here: https://uk.reuters.com/article/businessNews/idUKKBN2630OB